Noticias destacadas
Carreras profesionales
Awards & Accreditations
University of Nevada, Reno
Fundación de Renown Health
Recursos de medios
![Renown Public Relations Media Icon](/-/media/Project/Renown/RenownHealth/About/Images/Media-PR-Image/PR-image-96x96.png?h=96&iar=0&w=96&rev=0809e5a78af0443d854076a985693e0e&hash=E137D345669CAE6E6D56A711FDBAB16F)
Renown Health's public relations team supports media partners in finding experts on diverse health care topics. In addition, we provide information and answer all questions regarding Renown. We look forward to working with you.
-
Medios en el campus
A los fines de la confidencialidad del paciente, las políticas de Renown Health requieren que los medios de comunicación estén acompañados por el personal de Relaciones Públicas en todo momento.
El personal de Relaciones Públicas se complacerá en hacer los arreglos necesarios para el estacionamiento, notificará al personal del hospital correspondiente y lo ayudará a encontrar su destino.
Presentaciones/transmisiones en vivo
Los medios de comunicación pueden realizar reuniones presenciales y transmisiones en vivo en nuestros campus. A fin de proteger la confidencialidad del paciente y la fluidez del paso, un miembro del personal lo ayudará a encontrar la mejor ubicación para su historia.
Le pedimos que respete nuestra obligación de proteger el bienestar de nuestros pacientes y el derecho legal a la privacidad.
-
Consultas sobre el estado del paciente
Cumplimos con las reglamentaciones de la Ley de Portabilidad y Responsabilidad de Seguros de Salud de 1996 (Health Insurance Portability and Accountability Act, HIPAA) para todos los pacientes, incluidos los pacientes de interés público. Las reglamentaciones de la HIPAA especifican qué información puede y no puede divulgarse sin la autorización de un paciente.
Las reglamentaciones de privacidad del paciente solo nos permiten compartir información relacionada con el estado de aquellos pacientes que figuran en nuestro directorio.
Las consultas de los medios de comunicación requieren que se escriba correctamente el nombre y el apellido del paciente.
Definiciones de “estado” utilizadas por Renown Health
Al describir el estado de un paciente, solo podemos divulgar los siguientes estados de pacientes:
Bueno: los signos vitales, como el pulso, la temperatura y la presión arterial, se mantienen estables y dentro de los límites normales. El paciente está consciente, cómodo y no presenta complicaciones.
Regular: los signos vitales se mantienen estables y dentro de los límites normales. El paciente está consciente y alerta, aunque puede sentirse incómodo o adolorido, y puede tener complicaciones menores.
Grave: los signos vitales pueden ser inestables o estar fuera de los límites normales. El paciente está gravemente enfermo o lesionado y puede tener complicaciones importantes.
Crítico: los signos vitales son inestables o están fuera de los límites normales. Existen complicaciones importantes.
Nota: “Estable” no es un estado.
Comunicados de prensa
-
Research Shows Genetic Approaches to Breast Cancer Screenings Yield More Accurate Results
Clinical researchers with the Healthy Nevada Project co-author research paper with findings that emphasize the need for a comprehensive approach to breast cancer risk assessment – including a focus on genetic medicine – to help ensure that individuals at high risk are identified and supported proactively rather than reactively. Breast cancer is a leading cause of cancer death among women in the United States. According to the American Cancer Society, about 1 in 8 women will develop breast cancer and about 1 in 39 women will die from breast cancer. Breast cancer is associated with increased age, hereditary factors, obesity, and alcohol use. Since 1990, breast cancer death rates have declined progressively due to advancements in treatment and detection. In Nevada there are an estimated 2,310 new breast cancer cases a year, and genetic mutations such as in the genes BRCA1 or BRCA2 remain a top risk factor for this prevalent disease. Recognizing the urgency for progress in breast cancer research, a collaborative effort between physicians, advanced practice providers and scientists from the Healthy Nevada Project® (HNP) and Helix have unveiled groundbreaking research. This study explores how genetic screenings are a necessary supplement to traditional testing methods, together offering more accurate insights into a patient's likelihood of developing breast cancer in the future. HNP is operated by Renown Genomic Medicine and the Institute for Health Innovation and is one of the largest community-based population health studies in the country. Their team works in collaboration with Helix, a leader in precision health that delivers comprehensive genomic solutions. Together, this dynamic partnership aims to understand breast cancer risk factors and pave the way for more effective preventative measures. The combined research team studied 25,591 female HNP participants to evaluate the performance of different genetic screening approaches to identify women at high risk of breast cancer. The results of this research suggest that a combined monogenic, or single-gene, and polygenic, or multi-gene, approach to breast cancer screenings helped produce more accurate results and more closely identify study participants who have a high genetic risk of developing the disease. "Based on this research, we are advocating a shift in approach which would improve breast cancer risk assessment through a combination of effective family history ascertainment and genetic screening,” said Joseph Grzymski, PhD, principal investigator of the Healthy Nevada Project, research professor at the University of Nevada, Reno School of Medicine and co-author of the breast cancer research paper. “This tailored approach, founded on the assessment of individual genetic risk, not only intends to elevate patient well-being but also will improve efficiency and equity in healthcare." Complementing the team’s research on leveraging genetics to identify women at low genetic risk of breast cancer that could safely defer mammogram screenings by five to 10 years that was released in late 2023 in JAMA Oncology, the study suggests that incorporating genetic information can assist in personalizing breast cancer screenings and optimizing the use of screening resources. "Existing disparities persist across various facets of breast cancer screening and treatment; however, genetic screening is clearly a powerful tool to help facilitate early intervention for those at higher risk,” said Jamie Schnell Blitstein, APRN, a primary care nurse practitioner at Renown Health and co-author of the breast cancer research paper. “By placing a heightened focus on risk, we underscore the pivotal role of preventative breast cancer screening.” Despite the availability of effective methods for early screening, co-authors of this research found that 78 percent of women with a family history of breast cancer had their risk ascertained only after a breast cancer diagnosis. The findings emphasize the need for a comprehensive approach to breast cancer risk assessment – including a focus on genetic medicine – to help ensure that individuals at high risk are identified and supported proactively rather than reactively. “These findings that can profoundly impact how healthcare is delivered were only made possible by all the participants who were willing to consent to research,” said Alex Bolze, PhD from Helix and co-author of the publication. “Broad-scale collaboration projects like these between Renown Health and UNR that engage large populations where participants share both their genetic information as well as electronic health records drive advancements in preventative medicine, as well as fundamental biological research.” The research paper was officially accepted on Jan. 29, 2024, and will be published by Elsevier, Inc. on behalf of the American College of Medical Genetics and Genomics. The contents of the paper will appear in the international journal Genetics in Medicine Open. Read the full article by visiting sciencedirect.com. The Healthy Nevada Project is currently recruiting new study participants. Free to all Nevadans with a saliva sample or blood draw, participants and their referring providers receive access to whole-exome sequencing and clinical grade results that help provide insight into their unique genetic risks tied to heart disease and certain cancers. If you are interested in enrolling in the study, schedule a Virtual Consent Appointment through MyChart or contact the Renown Institute for Health Innovation at RenownIHI@renown.org or (775) 982-6914 to be connected to a Genomic Representative. About Renown Health Renown Health is the region’s largest, not-for-profit integrated healthcare network serving Nevada, Lake Tahoe and northeast California. Con una fuerza laboral diversa de más de 7,000 empleados, Renown ha fomentado una cultura de excelencia, determinación e innovación de larga data. La organización se compone de un centro de urgencias, dos hospitales de cuidados agudos, un hospital infantil, un hospital de rehabilitación, un grupo médico y una red de atención de urgencias y Hometown Health, la compañía de seguros sin fines de lucro más grande de la región y de propiedad local, Hometown Health. Renown is currently enrolling participants in the largest community-based genetic population health study, the Healthy Nevada Project®. To join the Renown Health team, visit renown.org/careers. Acerca de Helix Helix es la compañía líder en genómica y vigilancia viral de la población cuyas operaciones se basan en el cuidado clínico, la investigación y el análisis de datos. Helix enables health systems, life sciences companies, payers, and government partners to accelerate the integration of genomic data into patient care and public health decision-making. Learn more at helix.com.
-
Give the Gift of Health This Season with ELF Testing
Renown Health and the University of Nevada, Reno School of Medicine give the gift of early diagnosis and disease prevention this holiday season. With the season of giving upon us, give yourself the gift of health. The Renown Institute for Health Innovation (IHI) and the University of Nevada, Reno School of Medicine (UNR Med) are excited to offer a free Enhanced Liver Fibrosis (ELFTM) test to patients at risk for a common type of liver disease, e.g. metabolic and nonalcoholic steatohepatitis (M/NASH), and who enroll or are currently enrolled in the Healthy Nevada Project. The ELF Test is an FDA (Food and Drug Administration) approved non-invasive test to help identify people most at risk for liver scarring, e.g. cirrhosis, and allows doctors to intervene before irreversible damage occurs. If undetected and untreated, M/NASH can result in liver cirrhosis which could require liver transplantation or lead to death. This test is important as the symptoms of M/NASH can be silent or non-specific, making it difficult to diagnose. “There are currently more than 11,000 people across the U.S. on the national liver transplant waiting list, and with the heightened prevalence of NAFLD and M/NASH, this number is projected to keep rising; however, with research such as the ELF Test at our disposal, we are continuing to find ways to improve the health of those at risk for advanced liver disease,” said Bill Plauth, MD, Chief Medical Officer for Renown Health and Associate Dean of Clinical Affairs at UNR Med. “We encourage our community to participate in this early risk detection. Through this sophisticated, noninvasive, blood test, our physicians and Advanced Practice Providers can better evaluate liver fibrosis to help those affected and enable researchers to improve the prevention and treatment of nonalcoholic liver disease as a whole.” This liver health-focused sub-study of the Healthy Nevada Project seeks to enhance the understanding of both NAFLD and M/NASH and to help inform the development of treatment options for these conditions, as few currently exist. “Providing access to cutting-edge innovations such as the ELF Test is critical for both participants and the physicians and advanced practice providers that care for them.” said Joseph Grzymski, PhD, principal investigator of the Healthy Nevada Project and the Liver Disease Study and research professor at UNR Med. Those interested in determining their risk for M/NASH and its progression are encouraged to enroll in the Metabolic & Nonalcoholic Steatohepatitis study. Those who have consented and participated in the M/NASH research will be eligible and contacted with more information on how to receive the ELF Test. The Renown IHI is also happy to connect with physicians and Advanced Practice Providers interested in having their patients enroll in the Healthy Nevada Project and join the study. For members of the community who would like more information and learn how to enroll, please contact the Renown IHI at RenownIHI@renown.org or (775) 982-6914 to be connected to a Genomic Representative. About the ELF™ Test The ELF Test is a noninvasive blood test that can quickly identify which patients are at an elevated risk for developing cirrhosis and other liver-related clinical events (LREs). In contrast to standard liver enzyme tests that reflect liver damage that has already occurred, the ELF Test combines three serum direct biomarkers of active fibrosis. The ELF Test algorithm measures each of these biomarkers to create an ELF score, which can be used as an aid to assess the risk for future disease progression. Doctors may use this ELF score to help evaluate if a patient requires increased medical care and monitoring for their condition. Individuals interested in determining their risk for NASH and its progression are encouraged to enroll in the Nonalcoholic Steatohepatitis Liver Disease Genome Atlas study. Those who have already consented and participated in the study will be contacted with more information on how to receive an ELF blood test. Para obtener más información o para inscribirse, comuníquese a la casilla de correo RenownIHI@renown.org o al teléfono (775) 982-6914. In the U.S., the ELF Testing Service is available from Brio Clinical, Inc., a CLIA-certified laboratory offering specialized testing throughout the United States. Brio Clinical is regulated under CLIA as qualified to perform high complexity testing.
Leer más About Give the Gift of Health This Season with ELF Testing
-
Elevated Levels of Arsenic and Other Metals Found In Nevada Private Wells
Study shows that many household wells need better drinking water treatment and monitoring Outside of Nevada’s bustling cities, private wells are the primary source of drinking water, serving 182,000 people. Yet some of the tested private wells in Nevada are contaminated with levels of heavy metals that exceed federal, state or health-based guidelines, a new study published in Science of The Total Environment shows. Consuming water contaminated by metals such as arsenic can cause adverse health effects. Scientists from DRI and the University of Hawaii Cancer Center recruited households with private wells through the Healthy Nevada Project. Households were sent free water testing kits, and participants were notified of their water quality results and recommended actions they could take. More than 170 households participated in the research, with the majority from Northern Nevada around Reno, Carson City and Fallon. “The goals of the Healthy Nevada project are to understand how genetics, environment, social factors, and healthcare interact. We directly engaged our participants to better understand environmental contaminants that may cause adverse health outcomes,” said co-author Joseph Grzymski, PhD, research professor at DRI, principal investigator of the Healthy Nevada Project®, and chief scientific officer for Renown Health. Nearly one-quarter (22%) of the private wells sampled had arsenic that exceeded safe levels determined by the Environmental Protection Agency (EPA) — with levels 80 times higher than the limit in some cases. Elevated levels of uranium, lead, cadmium, and iron were also found. “We know from previous research that Nevada’s arid climate and geologic landscape produce these heavy metals in our groundwater,” says Monica Arienzo, PhD, an associate research professor at DRI who led the study. “It was important for us to reach out to community members with private wells to see how this is impacting the safety of their drinking water.” Fewer than half (41%) of the wells sampled used water treatment systems, and some treated water samples still contained arsenic levels over EPA guidelines. Although average levels of heavy metal contaminants were lower in treated water, many homes were unable to reduce contaminants to levels considered safe. The state leaves private well owners responsible for monitoring their own water quality, and well water testing helps ensure water is safe to drink. This study shows that more frequent testing is needed to ensure Nevada’s rural communities have safe drinking water. This is particularly important as the effects of climate change and population growth alter the chemistry of groundwater, potentially increasing metal concentrations. “The results emphasize the importance of regular water quality monitoring and treatment systems,” said co-author Daniel Saftner, MS, assistant research scientist at DRI. Although the research focused on wells in Nevada, other arid communities in Western states are facing similar risks of water contamination. More information: The full study, Naturally Occurring Metals in Unregulated Domestic Wells in Nevada, USA, is available from Science of The Total Environment: doi.org/10.1016/j.scitotenv.2022.158277. This project was funded by an NIH award (#1R01ES030948-01). The Healthy Nevada Project was funded by grants from Renown Health and the Renown Health Foundation. Study authors included Monica M. Arienzo (DRI), Daniel Saftner (DRI), Steven N. Bacon (DRI), Erika Robtoy (DRI), Iva Neveux (DRI), Karen Schlauch (DRI), Michele Carbone (University of Hawaii Cancer Center) and Joseph Grzymski (DRI/Renown Health). About DRI The Desert Research Institute (DRI) is a recognized world leader in basic and applied environmental research. Comprometidos con la excelencia e integridad científicas, el cuerpo docente del DRI, los estudiantes que trabajan juntos y el personal han desarrollado conocimientos científicos y tecnologías innovadoras en proyectos de investigación en todo el mundo. Desde 1959, la investigación de DRI ha profundizado el conocimiento científico sobre temas que van desde el impacto de los seres humanos en el medioambiente hasta el impacto del medioambiente en los seres humanos. Los hallazgos científicos impactantes y las soluciones inspiradoras del DRI apoyan la economía diversa de Nevada, proporcionan oportunidades educativas basadas en la ciencia e informan a legisladores, líderes empresariales y miembros de la comunidad. El DRI tiene campus en Las Vegas y Reno y funciona como el grupo de investigación sin fines de lucro del Sistema de Educación Superior de Nevada. For more information, please visit dri.edu. About Renown Health Renown Health is Nevada’s largest, not-for-profit integrated healthcare network serving Nevada, Lake Tahoe, and northeast California. With a diverse workforce of more than 6,500 employees, Renown has fostered a longstanding culture of excellence, determination, and innovation. The organization comprises a trauma center, two acute care hospitals, a children’s hospital, a rehabilitation hospital, a medical group and urgent care network, and the locally owned not-for-profit insurance company, Hometown Health. Renown is currently enrolling participants in a community-based genetic population health study, the Healthy Nevada Project®. About the University of Hawaiʻi Cancer Center The University of Hawaiʻi Cancer Center through its various activities, including scientific research and clinical trials, adds more than $57 million to the Oʻahu economy. It is one of only 71 research institutions designated by the National Cancer Institute. An organized research unit within the University of Hawaiʻi at Mānoa, the UH Cancer Center is dedicated to eliminating cancer through research, education, patient care and community outreach with an emphasis on the unique ethnic, cultural, and environmental characteristics of Hawaiʻi and the Pacific. Obtenga más información en https://www.uhcancercenter.org. Like us on Facebook at facebook.com/UHCancerCenter. Follow us on Twitter @UHCancerCenter.
Leer más About Elevated Levels of Arsenic and Other Metals Found In Nevada Private Wells
-
Un estudio demuestra la importancia de garantizar el seguimiento del participante y del proveedor después de obtener el resultado de un examen de detección genético
Lanzada en asociación con el Desert Research Institute, una nueva investigación del proyecto Healthy Nevada Project® determina que un diagnóstico confirmado no siempre produce cambios en el cuidado del paciente. El hecho de entregar a las personas información de salud que pueda cambiar sus vidas no garantiza que las personas, o sus proveedores de atención médica, actuarán en consecuencia. La educación de seguimiento y las conversaciones sobre los planes de cuidado ejecutables con los pacientes y sus médicos son los próximos pasos clave, de acuerdo con la nueva investigación del Healthy Nevada Project. El Healthy Nevada Project es un proyecto de investigación y detección genética que se lanzó en 2016 como una asociación entre DRI y Renown Health. El proyecto ahora tiene más de 50,000 participantes y cuenta con secuenciación genética proporcionada por Helix. Entre septiembre de 2018 y septiembre de 2020, el Healthy Nevada Project notificó exitosamente a 293 participantes que estaban genéticamente en riesgo de desarrollar cáncer de pecho y ovario, síndrome de Lynch o hipercolesterolemia familiar hereditarios, tres afecciones genéticas comunes conocidas colectivamente como afecciones de Nivel 1 de los Centros para el Control y la Prevención de Enfermedades (Centers for Disease Control and Prevention, CDC). En un estudio publicado hoy en Frontiers in Genetics, los científicos del Healthy Nevada Project analizaron qué impacto tuvo el hecho de notificar a un paciente sobre un resultado positivo para una condición de Nivel 1 de los CDC en el cuidado que recibió el paciente en los meses y años posteriores. Según sus resultados, entre los 293 participantes del Healthy Nevada Project que fueron notificados del riesgo genético de desarrollar una afección del Nivel 1 de los CDC, el 71 % de participantes con registros médicos electrónicos compartieron sus hallazgos con los proveedores de atención médica. Sin embargo, solo el 30 % de los registros médicos electrónicos de estos pacientes contenía documentación del diagnóstico genético, y solo el 10 % de los pacientes examinados experimentó un posible cambio en el cuidado después de recibir los resultados de su examen de detección genético. “El Healthy Nevada Project se implementó con un enfoque ‘sin intervención’ en el que los participantes reciben sus hallazgos y deciden con quiénes y cuándo desean compartirlos. Los hallazgos no se agregaron automáticamente a sus registros médicos electrónicos”, explicó el Dr. Gai Elhanan, científico de datos médicos en DRI y coautor del estudio. “Lo que estamos aprendiendo ahora es que para garantizar que los hallazgos genéticos importantes se integren en el régimen de cuidado, es importante que su incorporación en los registros médicos electrónicos forme parte del estudio”. Este estudio se basa en investigaciones anteriores del Healthy Nevada Project publicadas en Nature Medicine. En ellas se demuestra la importancia de realizar exámenes de detección para las afecciones del Nivel 1 de los CDC, las cuales afectan a aproximadamente a 1 de cada 75 personas y se pueden mitigar e incluso se puede evitar que se conviertan en enfermedades cuando se detectan en forma temprana. Este estudio determinó que hasta el 90 % de los casos con afecciones del Nivel 1 de los CDC no son detectados por los proveedores clínicos en las evaluaciones y los exámenes de detección que se realizan durante las visitas de cuidado clínico habitual. Durante el estudio actual, los científicos del Healthy Nevada Project descubrieron que el 19 % de participantes estudiados ya había desarrollado una de las afecciones del Nivel 1 de los CDC y, por lo tanto, podrían haberse beneficiado de una notificación más temprana sobre su afección. El equipo del estudio espera que sus hallazgos estimulen a los residentes de Nevada a obtener pruebas genéticas para estas afecciones relativamente comunes. Incluso si las personas son mayores o ya han sufrido enfermedades relacionadas con estas afecciones, las pruebas también podrían ser beneficiosas para los hermanos, los niños y los nietos que también pueden estar en riesgo y que posteriormente podrían someterse a exámenes de detección en caso de un hallazgo positivo. El equipo del estudio también incita a informar a los proveedores de atención médica sobre la importancia de incorporar diagnósticos genéticos en las recomendaciones farmacéuticas (por ejemplo, para la hipercolesterolemia familiar) y de tratamiento a los pacientes. “Como resultado de este análisis, los médicos de Renown Health y los investigadores del Healthy Nevada Project han logrado cambios significativos, lo que incluye la obtención del consentimiento informado de los participantes para incorporar hallazgos positivos de sus informes genéticos directamente en su registro médico electrónico”, explicó Daniel Kiser, M.S., científico auxiliar de investigación de ciencia de datos en DRI y coautor del estudio. “Esto ayudará tanto a los participantes como a sus proveedores de cuidado clínico, y a todo el estado a maximizar los beneficios a largo plazo de los exámenes de detección genéticos voluntarios basados en la población del Healthy Nevada Project”. Información adicional: El texto completo del estudio, Incomplete Penetrance of Population-Based Genetic Screening Results in Electronic Health Record, está disponible en Frontiers in Genetics: https://www.frontiersin.org/articles/10.3389/fgene.2022.866169/full?&utm_source=Email_to_authors_&utm_medium=Email&utm_content=T1_11.5e1_author&utm_campaign=Email_publication&field=&journalName=Frontiers_in_Genetics&id=866169. Este proyecto fue financiado por Renown Health, fundación de Renown Health y la Oficina de Desarrollo Económico del Gobernador de Nevada. Entre los autores del estudio se incluyen Gai Elhanan (DRI), Daniel Kiser (DRI), Iva Neveux (DRI), Shaun Dabe (Renown Health), Alexander Bolze (Helix), William Metcalf (DRI), James Lu (Helix) y Joseph Grzymski (DRI/Renown Health). Para obtener más información sobre el Healthy Nevada Project® o para solicitar un examen de detección genético, visite: https://healthynv.org/ Acerca del DRI El Desert Research Institute (DRI) es un reconocido líder mundial en investigación ambiental básica y aplicada. Comprometidos con la excelencia e integridad científicas, el cuerpo docente del DRI, los estudiantes que trabajan juntos y el personal han desarrollado conocimientos científicos y tecnologías innovadoras en proyectos de investigación en todo el mundo. Desde 1959, la investigación de DRI ha profundizado el conocimiento científico sobre temas que van desde el impacto de los seres humanos en el medioambiente hasta el impacto del medioambiente en los seres humanos. Los hallazgos científicos impactantes y las soluciones inspiradoras del DRI apoyan la economía diversa de Nevada, proporcionan oportunidades educativas basadas en la ciencia e informan a legisladores, líderes empresariales y miembros de la comunidad. El DRI tiene campus en Las Vegas y Reno y funciona como el grupo de investigación sin fines de lucro del Sistema de Educación Superior de Nevada. Para obtener más información, visite www.dri.edu. Acerca de Renown Health Renown Health es la red de atención médica integrada de administración local y sin fines de lucro más grande de la región, que presta servicios a Nevada, Lake Tahoe y el noreste de California. Con una fuerza laboral diversa de más de 7,000 empleados, Renown ha fomentado una cultura de excelencia, determinación e innovación de larga data. La organización se compone de un centro de urgencias, dos hospitales de cuidados agudos, un hospital infantil, un hospital de rehabilitación, un grupo médico y una red de atención de urgencias y Hometown Health, la compañía de seguros sin fines de lucro más grande de la región y de propiedad local, Hometown Health. Actualmente, Renown está inscribiendo participantes en el estudio genético de salud poblacional basado en la comunidad más grande del mundo, el Healthy Nevada Project®. Visite renown.org para obtener más información. Acerca de Helix Helix es la compañía líder en genómica y vigilancia viral de la población cuyas operaciones se basan en el cuidado clínico, la investigación y el análisis de datos. Helix permite que los sistemas de salud, las empresas de ciencias biológicas, los pagadores y los socios gubernamentales aceleren la integración de los datos genómicos en el cuidado médico del paciente y en la toma de decisiones de salud pública. Obtenga más información en www.helix.com.
-
¿El mejor regalo? ¡Una familia totalmente vacunada!
Renown se une al Distrito de Salud del Condado de Washoe para ofrecer vacunas contra la COVID-19 a niños de entre 5 y 11 años en clínicas de vacunación. Renown Health se asocia con el Distrito de Salud del Condado de Washoe para ayudar a distribuir los suministros inicialmente disponibles y limitados de una dosis apropiada según la edad de las vacunas de Pfizer-BioNTech contra la COVID-19 a niños de entre 5 y 11 años. En este momento, todos los residentes mayores de 5 años son elegibles para recibir una vacuna. Renown anunció hoy que para los padres o tutores que tienen acceso a la aplicación MyChart de Renown como representantes de sus hijos, ahora hay disponibles citas de vacunación para niños de entre 5 y 11 años. Cuando se reciban los suministros, Renown espera poder vacunar a 1,600 niños con la serie de dos dosis en una cantidad limitada de centros de fin de semana. At this time, due to limited supplies, no vaccines for children are available through Renown Medical Group pediatric offices. Vaccine appointments may only be scheduled through the Renown MyChart app; please do not contact a Renown doctor/health care provider or the Engagement Center at this time. There is no cost to establish a Renown MyChart account, and you do not need to have a Renown provider to enroll. Para obtener asistencia técnica para MyChart, llame al 775-982-2781. Renown is covering all costs of the vaccine, and it is offered free of charge. “As a pediatrician, an intensive care physician, a public health practitioner and a grandparent, I encourage parents to vaccinate their children against COVID-19 now. No child should suffer, be hospitalized or die from a disease that can prevented by simply getting a shot,” says Tony Slonim, MD, DrPH, President & CEO of Renown Health. “We remain steadfast in fighting the good fight for our community, and that includes protecting kids. Being able to serve kids and their parents, with the only Children’s Hospital in northern Nevada, and being able to administer COVID-19 vaccines to children is incredibly gratifying for our team. This vaccine will prevent deaths, ICU admissions and will prevent significant long-term adverse outcomes in children." “I tell parents, get your kids vaccinated now- because every kid is at risk,” says Kristina Deeter, M.D., MBA, Pediatric Intensivist, and Vice Chair of Pediatrics at Renown Children’s Hospital. “Please get your family- including your kids, vaccinated now to keep your family safe. Being fully vaccinated and being able to hug Grandma and Grandpa at the holidays may be the greatest gift of all this holiday season.” “Los CDC recomiendan que todas las personas mayores de 5 años reciban una vacuna contra la COVID-19 para ayudar a protegerse de la COVID-19. Widespread vaccination for COVID-19 is a critical tool to protect everyone, especially those at highest risk, from severe illness and death. Currently, the Pfizer vaccine is the only option currently authorized for children,” says Vanessa Slots, MD, a pediatrician with Renown Children’s. “It was found to give kids strong protection against COVID-19, including against the Delta variant. Children who are vaccinated may have some side effects (chills, redness and swelling at site injection), which are normal signs that their body is building protection.” Children are advised not to receive the vaccine if: • They are ill at the time of vaccination (fever, shortness of breath, vomiting, diarrhea or acute illness). • se les ha diagnosticado COVID-19 en los 14 días anteriores; • They have a history of significant allergic reaction to any of the ingredients in the vaccine. About Renown Health Renown Health is the region’s largest not-for-profit integrated healthcare network serving Nevada, Lake Tahoe and northeast California. Con una fuerza laboral diversa de más de 7,000 empleados, Renown ha fomentado una cultura de excelencia, determinación e innovación de larga data. La organización se compone de un centro de urgencias, dos hospitales de cuidados agudos, un hospital infantil, un hospital de rehabilitación, un grupo médico y una red de atención de urgencias y Hometown Health, la compañía de seguros sin fines de lucro más grande de la región y de propiedad local, Hometown Health. Actualmente, Renown está inscribiendo participantes en el estudio genético de salud poblacional basado en la comunidad más grande del mundo, el Healthy Nevada Project®. Visite renown.org para obtener más información.
Leer más About ¿El mejor regalo? ¡Una familia totalmente vacunada!
-
Lucha por su salud y seguridad; a medida que aumentan los casos de COVID-19, Renown está preparada.
Si tiene 12 años o más reciba una vacuna contra la COVID-19 y la cepa Delta para protegerse; busque atención de urgencia si es necesario. El mundo, el país y nuestra área continúan experimentando un aumento en los casos de COVID-19 y las hospitalizaciones por la cepa Delta del virus del SARS-CoV-2, la cual es altamente contagiosa. The Renown Health team continues to safely screen, diagnose and care for patients with respiratory illnesses, including those at risk for COVID-19. Renown continues to use current local and national data, analytics, and public data sets for predictive modeling in service to our community. Renown Health ensures constant readiness by working closely with the Washoe County Health District, the Governor’s office, and is informed by updates from the Centers for Disease Control and Prevention (CDC). When there is heightened concern around an illness, we implement enhanced infection prevention strategies to ensure we are ready with the appropriate supplies and alternate plans should the need arise. Renown Health providers are educated and prepared to quickly and safely screen, diagnose and care for patients with respiratory illness, including COVID-19. Vaccination is the best protection against Delta. “The most important action you can take to protect yourself from the Delta strain and the COVID-19 virus is to get fully vaccinated,” says Brion Hill, MD who practices at the Renown Urgent Care - Los Altos location. “El virus de la COVID19 y la cepa Delta se pueden prevenir y controlar con vacunas seguras y eficaces contra la COVID-19, que son gratuitas y ahora están ampliamente disponibles en nuestra área. Los CDC recomiendan que todas las personas mayores de 12 años se vacunen contra la COVID-19. Recent data show that nearly all COVID-19 deaths are now occurring among unvaccinated individuals.” A list of providers in our area offering vaccines is available at vaccines.gov.” Protecting Yourself, Friends and Family Dr. Hill adds, “You can protect yourself the same way you would protect against other viruses with a few common-sense practices.” Wear a cloth mask or medical procedure mask when in a public setting. For situations when you are in close contact with people who do not live with you, you may want to consider a mask option that provides a higher level of protection (improved fit and/or improved filtration). Wash your hands thoroughly and often. Make sure you are cleaning between your fingers and under your nails. Use alcohol-based sanitizers when soap and water are not available. Use disposable tissues when coughing and sneezing; dispose of carefully and promptly. If tissues are not available, direct your cough or sneeze into the crook of your arm/sleeve. Avoid touching your eyes, nose, and mouth with unwashed hands. Clean and disinfect frequently touched objects and surfaces. Avoid close contact with anyone who has cold or flu-like symptoms. Avoid shaking hands, especially with those who appear to be ill. Disinfect shared surfaces. Practique distanciamiento social, de 6 pies o más. Stay home when you are sick. If you have fever, cough, gastrointestinal, or respiratory symptoms please call your medical provider and explain your symptoms before coming in to their offices. If you do not have a health care provider, and have medical concerns that are urgent but not life-threatening, visit a Renown Urgent Care physician or healthcare provider. Virtual Urgent Care is available for people for COVID-19 symptoms and Virtual Urgent Care visits are available through MyChart. MyChart es un portal para pacientes seguro y gratuito en línea que le permite acceder a su registro médico de Renown Health y administrar su información de atención médica. Hay 11 oficinas de atención de Renown Urgent Care convenientemente ubicadas que cuentan con proveedores listos para verlo los 7 días de la semana. Tiene la opción de reservar con anticipación y programar una cita en 11 ubicaciones cercanas a usted. How to Get Accurate and Reliable Information: We continue to advise our community regarding the importance of accurate sources of information, and to provide regular updates. For up-to-date information on Renown’s approach to keeping our community safe, visit our website at renown.org. Acerca de Renown Health Renown Health es una red de atención médica integrada de administración local y sin fines de lucro que brinda servicios al norte de Nevada, Lake Tahoe y el noreste de California. Renown es uno de los mayores empleadores privados de la región y cuenta con una fuerza laboral de más de 7,000. It comprises three acute care hospitals, the region’s only children’s hospital, a rehabilitation hospital, the area’s most comprehensive medical group and urgent care network, and the region’s largest not-for-profit insurance company, Hometown Health. Renown has a long tradition and commitment to improving the care and the health of our community. Visite renown.org para obtener más información.
-
Renown Thanks Community as COVID-19 Drive-Thru Ends
Después de administrar más de 73,000 vacunas de primera y segunda dosis a nuestra comunidad, el equipo de vacunación de Renown concluirá sus esfuerzos en el centro de vacunación al paso de Renown a finales de este mes. Renown Health has been pleased to work with the Washoe County Health District, the state, and the CDC to distribute the limited supplies of COVID-19 vaccines. Los líderes de la fuerza de trabajo que administra las vacunas contra la COVID-19 en Renown anunciaron hoy que el miércoles, 12 de mayo de 2021 será el último día en que la organización administrará la primera dosis de la vacuna contra la COVID-19 a los miembros de la comunidad en la clínica de vacunación al paso. La clínica de vacunas de Renown permanecerá abierta hasta que todas las personas que reciban su primera dosis de la vacuna a través de Renown tengan la oportunidad de recibir su segunda dosis. Hasta la fecha, el equipo de vacunas de Renown ha administrado más de 73,000 dosis 1 y 2 a miembros del personal médico, empleados de Renown, estudiantes, voluntarios y miembros de la comunidad elegibles. “It has been an honor assisting our local and statewide health partners in the herculean feat of vaccinating the hundreds of thousands of area residents excited to receive the vaccine,” said Tony Slonim, MD, DrPH, President and CEO of Renown Health. “As we conclude our efforts at our drive-thru vaccine clinic, we are glad to continue working closely with our community health leaders and be ready to assist once again should there be a need for our support in the future. We are proud to be part of the solution for our community and pleased to have made a genuine difference in the health and well-being of others throughout this unprecedented time in our history.” “Mientras miramos hacia un futuro mejor más allá de la pandemia, no podemos dejar de reflexionar sobre las más de 73,000 dosis de vacunas que nuestros equipos administraron a nuestra comunidad”, declaró Melodie Osborn, RN (enfermera certificada), directora de Enfermería y Calidad de Servicios de Salud en Renown. “From our nurses, pharmacists, security teams, public safety experts and countless volunteer staff, each dose of the vaccine was made possible—rain, snow or shine—by dedicated healthcare champions committed to the health and safety of northern Nevadans.” “We want to offer our sincere gratitude and appreciation to the public for placing their trust in Renown to receive their vaccines, and for their patience and support of this important work,” said Wendy Meyers, Manager of Health and Wellness at Hometown Health. “The masked smiles, emotional tears of gratitude and relief, heartfelt thanks, food deliveries and many other acts of kindness will forever hold a special place in our hearts.” Los miembros de la comunidad mayores de 16 años que aún estén interesados en recibir la vacuna de Pfizer en Renown el 12 de mayo están invitados a programar una cita a través de MyChart; se aceptarán visitas sin cita desde las 12 p. m. hasta las 2 p.m. Los menores de 16 y 17 años deben estar acompañados por su padre, madre o tutor para recibir la vacuna. Para obtener asistencia, llame al 775-982-2781. To schedule your COVID-19 appointment in Washoe County outside of Renown, please visit covid19washoe.com. Renown will continue providing ongoing updates to help keep our community safe on our website at covid.renown.org. Acerca de Renown Health Renown Health es la red de atención médica integrada de administración local y sin fines de lucro más grande de la región, que presta servicios a Nevada, Lake Tahoe y el noreste de California. Con una fuerza laboral diversa de más de 7,000 empleados, Renown ha fomentado una cultura de excelencia, determinación e innovación de larga data. La organización se compone de un centro de urgencias, dos hospitales de cuidados agudos, un hospital infantil, un hospital de rehabilitación, un grupo médico y una red de atención de urgencias y Hometown Health, la compañía de seguros sin fines de lucro más grande de la región y de propiedad local, Hometown Health. Clinical institutes include; Cancer, Heart and Vascular Heath and Neurosciences. Actualmente, Renown está inscribiendo participantes en el estudio genético de salud poblacional basado en la comunidad más grande del mundo, el Healthy Nevada Project®. Para obtener más información, visite renown.org.
Leer más About Renown Thanks Community as COVID-19 Drive-Thru Ends
-
Businesses: Get Employees Vaccinated Against COVID-19 for Free
Renown Health has been working with the Washoe County Health District, the state, and the CDC to distribute the limited supplies of COVID-19 vaccines. Renown ha administrado más de 64,000 dosis 1 y 2 de vacunas hasta la fecha, lo que incluye a todos los miembros del nivel 1A (miembros del personal médico, empleados de Renown, estudiantes y voluntarios) y a los miembros de la comunidad que reúnen los requisitos, lo que ahora incluye a todos los mayores de 16 años. “En Renown, estamos entusiasmados por continuar con nuestro objetivo de ofrecer la oportunidad de vacunarse a todo aquel que esté interesado en hacerlo, sin costo alguno”, dijo Tony Slonim, MD, DrPH, presidente y director ejecutivo de Renown Health. “We would like local businesses to know we have thousands of open appointments in early May and we encourage our business colleagues to share this information with employees so they may easily schedule an appointment through MyChart and continue on the path to a healthier and safer northern Nevada.” “Renown is excited to continue along our goal of providing the opportunity for everyone who is interested in receiving the vaccine to be vaccinated at no charge,” said Tony Slonim, MD, DrPH, President and CEO of Renown Health. “Nos gustaría que las empresas locales supieran que tenemos miles de citas disponibles a principios de mayo y animamos a nuestros colegas de negocios a compartir esta información con los empleados para que puedan programar fácilmente una cita a través de MyChart y continuar en el camino hacia un norte de Nevada más saludable y seguro”. Citas de vacunación para mayores de 18 años Cualquier persona mayor de 18 años puede registrarse para obtener una cuenta gratuita de Renown EPIC MyChart. They do not need to have a Renown provider to enroll. With a MyChart account, they will be able to login and schedule their first vaccine appointment. These vaccines require two doses. After the first dose of the vaccine is documented in your MyChart account, you will get a notice to schedule your second dose. There are two easy ways to sign up for MyChart. Please see instructions in both English and Spanish. Para programar una cita para una persona de 16 o 17 años: Hemos hecho arreglos especiales para menores de 16 y 17 años. Complete este formulario, que también se encuentra en https://covid.renown.org/vaccine/. El equipo de Comunicación con el Cliente de Renown llamará al número de teléfono indicado en un plazo de 14 días hábiles para programar la cita. We appreciate your patience during this time as demand is high. Please note that a parent or guardian must accompany the teen when getting their vaccination. You are advised NOT to receive the vaccine if you: Are ill at the time of vaccination (fever, shortness of breath, vomiting, diarrhea or acute illness). Se le ha diagnosticado COVID-19 en los últimos 14 días. Recibió alguna otra vacuna en los últimos 14 días. Have a history of significant allergic reaction to this vaccine or any of its ingredients. “Hometown Health is proud to be part of an organization offering COVID-19 vaccines to our community at no cost,” said David Hansen, CEO, Hometown Health. “The business community in northern Nevada is an important piece of the vaccination puzzle, and as a community-focused organization, we are pleased that Renown can safely offer vaccinations to local businesses and contribute to an increased hope for the future.” Renown will provide additional updates on our websites at covid.renown.org. Please see b-roll, photos and fly-over footage of our Drive-Thru COVID-19 Vaccination Clinic here. Acerca de Renown Health Renown Health es la red de atención médica integrada de administración local y sin fines de lucro más grande de la región, que presta servicios a Nevada, Lake Tahoe y el noreste de California. Con una fuerza laboral diversa de más de 7,000 empleados, Renown ha fomentado una cultura de excelencia, determinación e innovación de larga data. La organización se compone de un centro de urgencias, dos hospitales de cuidados agudos, un hospital infantil, un hospital de rehabilitación, un grupo médico y una red de atención de urgencias y Hometown Health, la compañía de seguros sin fines de lucro más grande de la región y de propiedad local, Hometown Health. Clinical institutes include; Cancer, Heart and Vascular Heath and Neurosciences. Actualmente, Renown está inscribiendo participantes en el estudio genético de salud poblacional basado en la comunidad más grande del mundo, el Healthy Nevada Project®. Para obtener más información, visite renown.org.
Leer más About Businesses: Get Employees Vaccinated Against COVID-19 for Free
-
Los principales hospitales de Estados Unidos se unen para promover la vacuna contra la COVID-19
Una coalición de los 60 mejores hospitales e instituciones de atención médica han unido fuerzas en una campaña nacional para alentar a los adultos a vacunarse contra la COVID-19. Led by Cleveland Clinic and Mayo Clinic, the campaign "Get the Vaccine to Save Lives" is designed to reassure the public that vaccines are safe, effective and necessary to achieve herd immunity and return to normal activities. "We're asking people to talk to their healthcare providers if they have questions and then get vaccinated," says Gianrico Farrugia, M.D., Mayo Clinic's president and CEO. "The vaccine is our strongest asset to end the pandemic, and I urge everyone who is eligible to get whichever vaccine you're first offered to save lives." The campaign hopes to reach adults who are hesitant to receive a vaccine, including racial and minority ethnic groups and people living in rural communities. Según una encuesta de la Kaiser Family Foundation publicada en marzo de 30, el 17 % de los encuestados manifiesta que adoptará una actitud de espera antes de vacunarse, y el otro 20 % manifiesta que nunca se vacunará o que solo lo hará si se le exige para el trabajo, la escuela o demás actividades. This leaves a significant portion of the population at risk of going unvaccinated. The nationwide campaign includes print and digital advertising, media outreach, social media, an awareness video and an informational website. "The COVID-19 vaccine is safe and highly effective and offers our best hope for beating the disease," said Tom Mihaljevic, M.D., Cleveland Clinic's CEO and president. "We all want to see a return to our pre-COVID routines, when we can once again gather safely with family and friends. To reach that goal, we must improve vaccination rates to achieve herd immunity. Please sign up today because we are all in this together." With vaccine distribution underway, the campaign aims to help Americans feel safe and confident about receiving a vaccine. Para lograr la inmunidad de rebaño y ayudar a poner fin a la pandemia, los principales funcionarios de salud dicen que al menos el 75 % de la población necesita recibir una vacuna. Herd immunity occurs when a large portion of a community becomes immune to a disease, making the spread of disease from person to person unlikely. As a result, the whole community becomes protected — not just those who have been vaccinated. Además de Mayo Clinic y Cleveland Clinic, otras 58 instituciones líderes en atención médica de los EE. UU. se han unido a la campaña. Esto incluye lo siguiente: Advent Health Adventist Health Allegheny Health Network Ann & Robert H. Lurie Children’s Hospital of Chicago Arizona Medical Association Ascension St. Vincent’s Atrium Health Banner Health Baptist Health South Florida Baylor Scott & White Health Beaumont Health BJC HealthCare Brooks Rehabilitation Broward Health Centura Health Einstein Healthcare Network Emory Healthcare Essentia Health Hackensack Meridian Honor Health Intermountain Healthcare Lee Health Mass General Brigham McLaren St. Luke’s MedStar Health Memorial Healthcare System Memorial Sloan Kettering Cancer Center Mercy Health Michigan Medicine Monument Health NCH Healthcare System Nicklaus Children’s Health System North Shore University Health System Northwestern Medicine Norton Healthcare Peace Health Piedmont Healthcare ProMedica Renown Health Rush University Medical Center Chicago Southwestern Health Resources Spectrum Health Summit Health Texas Health The Ohio State University Wexner Medical Center y el The James Cancer Hospital The Toledo Clinic The University of Texas MD Anderson Cancer Center Theda Care UC Health (Cincinnati) UNC Health University Hospitals University of Chicago Medicine University of Iowa Health Care University of Toledo Medical Center UT Southwestern Medical Center Virtua Health Well Span Health Yale New Haven Health En los Estados Unidos, se han administrado más de 209 millones de dosis de la vacuna contra la COVID-19 y el 50 % de la población mayor de 18 años ha recibido al menos una dosis de la vacuna al 18 de abril, según los Centros de Control y Prevención de Enfermedades. COVID-19 vaccines were evaluated in tens of thousands of participants in clinical trials. The vaccines met the Food and Drug Administration's rigorous scientific standards for safety, effectiveness, and manufacturing quality needed to support emergency use authorization. Ethos Creative Group of Burlington, North Carolina, created the campaign and donated their services. Facebook, iHeartRadio, Spectrum Reach, The New York Times, The Washington Post, USA Today, and YouTube also provided complimentary resources. For more information about the campaign, visit ourshot2savelives.org About Renown Health Renown Health is the region’s largest, locally governed, not-for-profit integrated healthcare network serving Nevada, Lake Tahoe and northeast California. Con una fuerza laboral diversa de más de 7,000 empleados, Renown ha fomentado una cultura de excelencia, determinación e innovación de larga data. La organización cuenta con un centro de urgencias, dos hospitales de cuidados agudos, un hospital para niños, un hospital de rehabilitación, un grupo médico y una red de atención de urgencia, y la compañía de seguros sin fines de lucro de propiedad local más grande de la región, Hometown Health. Clinical institutes include: Cancer, Heart and Vascular Heath and Neurosciences. Actualmente, Renown está inscribiendo participantes en el estudio genético de salud poblacional basado en la comunidad más grande del mundo, el Healthy Nevada Project®. For more information, visit renown.org.
-
Final Doses of COVID-19 Vaccines Administered to Renown Physicians
Renown Health is working with the Washoe County Health District (WCHD), the state, and the Centers for Disease Control and Prevention (CDC) to distribute the initially available, limited supplies of COVID-19 vaccines. Because there may be limited supply, the vaccine continues to be distributed in a tiered approach. Today, the light at the end of the tunnel shined brighter than ever as many of Renown’s Tier 1A recipients received their second and final doses. Please see B-roll from today's event and photos, B-roll and interviews from the first event here. An important pandemic milestone “The health and safety of our staff is our top priority, and we remain steadfast in our determination to fight the good fight for our community. Administration of the final doses of the vaccine is an important pandemic milestone as it brings an overwhelming sense of hope and relief to all of us at Renown,” said Tony Slonim, MD, DrPH, President & CEO of Renown Health. “Los héroes de la atención médica que recibieron la vacuna hoy han estado luchando contra esta pandemia en las primeras líneas y han trabajado sin descanso durante los últimos 11 meses para mantener a nuestra comunidad segura. It’s reassuring knowing they have an added, strong layer of protection, so they can focus their efforts on putting an end to this long and difficult battle.” Today, Renown healthcare workers received the second dose of the Pfizer-BioNTech vaccine which received emergency use authorization from the Food and Drug Administration last month. Esta dosis, que se administra 21 días después de la primera, marca la dosis final de la serie de vacunación. Muchos empleados de Renown también han recibido la vacuna de Moderna, cuyas segundas dosis se administrarán después de los 28 días. Los entresijos de la administración de la vacuna El proceso de vacunación contra la COVID-19 de Renown incluye la programación por parte de los médicos y empleados a través del registro médico electrónico EPIC MyChart que utiliza Renown. Employees are masked, and in their personal vehicles, as they drive through the vaccination site at Hometown Health. Each physician and healthcare worker provides their verification, identification, documentation and consent. They then extend their upper arm to receive the vaccination. Following the receipt of the vaccination, they have a 15-minute observation period to assure they do not experience any immediate side effects. Similar to receiving the first dose, these Tier 1A healthcare employees were encouraged to schedule their vaccination after their completed work schedule to have time to rest. As with all vaccinations, there is a potential for injection site reactions (redness, swelling and pain) as well as fever, fatigue, headache, chills, vomiting, diarrhea, muscle pain and/or joint pain. Fever is not an infrequent side effect, especially on the second dose, so these vaccinated employees will self-monitor their temperatures, as they cannot work at Renown with a fever. Renown invited media to help commemorate this triumphant vaccination event. Present during today’s event were- Dr. Bret Frey, representing the Medical Staff and Emergency Medicine physicians at Renown; Dr. Jacob Keeperman, Medical Director, Renown Regional Transfer and Operations Center representing physicians in Renown’s Intensive Care Unit; and Holly Irwin, a Clinical Respiratory Therapist. La vacuna: una herramienta más para ayudar a combatir la pandemia “La mejor protección contra la COVID-19 será una combinación de medidas, como vacunarse contra la COVID-19, usar mascarilla, mantenerse al menos a 6 pies de distancia de otras personas, evitar las multitudes y lavarse las manos con frecuencia”, explica Amy McCombs, MSN (máster en enfermería), RN (enfermera certificada), CCRN (enfermera registrada de cuidado intensivo), CNML (gerente de enfermería certificada y líder), vicepresidenta de Calidad de Servicios Agudos en Renown y defensora del esfuerzo de vacunación en Renown. “No one tool alone will stop this pandemic, it will take a combination of all of us using all of these efforts to fight the spread of this virus. We are getting closer to widespread vaccine development every day; however, until then, everyone must remain vigilant, take precautions and follow public health orders.” “This vaccination is a game-changer in terms of improving the health of our community,” said Paul Sierzenski, MD, MSHQS, Chief Medical Officer, Acute Services, Renown Health. "Given the demands of this COVID-19 pandemic, we are pleased to be able to provide second doses of this vaccination to help in the fight. We continue to follow CDC recommendations for a tiered approach to vaccine distribution. Our goal is that by spring, all Renown physicians; employees and their family members; and all Hometown Health members and Renown patients interested in receiving the vaccine will have an opportunity to be vaccinated.” The COVID-19 vaccine is not mandatory for all Renown employees, but is strongly advised. Renown is covering all costs of the vaccine, and it is being offered free of charge to employees. Regístrese en Renown EPIC MyChart ahora. Para simplificar el proceso de notificación, consentimiento, programación y recordatorio para la distribución de vacunas, y para publicar en el sistema estatal de información de inmunización Web IZ de Nevada, las personas que estén interesadas en recibir la vacuna a través de Renown tendrán que registrarse y obtener una cuenta EPIC MyChart. Manténgase actualizado sobre la COVID-19 Renown Health está preparada para evaluar, diagnosticar y atender de manera segura a pacientes con enfermedad respiratoria, incluida la COVID-19. Para mantenerse actualizado sobre las comunicaciones relacionadas con la distribución de la vacuna contra la COVID-19 por parte de Renown, las preguntas frecuentes y la evidencia científica detrás de la vacuna, visite https://covid.renown.org/ Únase al equipo de Renown Renown Health continúa comprometido con la contratación de personas para ocupar puestos clave en la organización para apoyar la salud y el bienestar de nuestra comunidad. Para unirse a la familia de Renown y luchar por la causa justa, postule en línea en https://careers.renown.org/ Apoye al equipo de Renown Renown Health, una organización benéfica sin fines de lucro, está muy agradecida por el apoyo de la comunidad durante estos momentos sin precedentes. Para donar a pacientes o proveedores de Renown, visite https://www.renown.org/donations-covid-19/. About Renown Health Renown Health is a locally governed and locally owned, not-for-profit integrated healthcare network serving northern Nevada, Lake Tahoe and northeast California. Renown es uno de los mayores empleadores privados de la región y cuenta con una fuerza laboral de más de 7,000. It comprises three acute care hospitals, a rehabilitation hospital, the area’s most comprehensive medical group and urgent care network, and the region’s largest and only locally owned not-for-profit insurance company, Hometown Health. Renown has a long tradition and commitment to continually improve the care and the health of our community. For more information, visit renown.org. About the Washoe County Health District The Washoe County Health District has jurisdiction over all public health matters in Reno, Sparks, and Washoe County through the policy-making Washoe County District Board of Health. The District consists of five divisions: Administrative Health Services, Air Quality Management, Community and Clinical Health Services, Environmental Health Services and Epidemiology & Public Health Preparedness. More info can be found here.
Leer más About Final Doses of COVID-19 Vaccines Administered to Renown Physicians
-
First COVID-19 Vaccines Administered to Physicians Today
This week, many of the nation’s health care systems in communities across the U.S. began vaccinating physicians and health care workers caring for patients with COVID-19. Many of these health care heroes have been on the front-line of this pandemic and working around-the clock over the last ten months. Las vacunas son una señal de esperanza para el futuro Aquí, en el condado de Washoe, hoy marca el muy deseado inicio de lo que los expertos en salud pública y medicina esperan que sea una ola nacional de vacunas que señale el comienzo del final de la pandemia de la COVID-19. La buena noticia de hoy de Renown coincidió con un nuevo hito negativo para el condado de Washoe: 384 muertes por COVID-19 confirmadas y más de 13,579 casos activos en una población de casi 500,000 personas. COVID-19 positivity test results and hospitalizations continue to be high across the country, our state and here in northern Nevada; straining hospital capacity, physicians and healthcare workers. Today we saw a bright light at the end of this dark tunnel. Renown began vaccinating health care workers caring for patients with COVID-19, and invited media to view the first vaccinations of those on the front-line of COVID-19. One vaccine, a Herculean effort of thousands “Although the vaccination process as you see it here looks relatively simple, it took a herculean logistical effort to implement the COVID-19 vaccination process that has begun today,” said Tony Slonim, MD, DrPH, President & CEO of Renown Health. “Today, thanks to the synchronized efforts of thousands of people and organizations across the country, we give thanks for this vaccination provided to Luis Martinez, an excellent ambassador for the thousands of healthcare heroes caring for patients with COVID-19. The health and safety of our staff is our top priority, and we remain steadfast in our determination to fight the good fight for our community.” Luis, on the front-line of the COVID-19 pandemic, receives 1st vaccine from Renown Luis Martinez received the 1st of his Pfizer-BioNTech vaccine which received emergency use authorization from the Food and Drug Administration last week. Recibirá la segunda y última vacuna de la serie en 21 días. La primera dosis de la vacuna se le administró a Luis fuera de su vehículo para que las cámaras pudieran capturar la experiencia. El proceso de vacunación contra la COVID-19 de Renown incluye programar previamente a médicos y empleados mediante el registro médico electrónico EPIC MyChart que usa Renown. Employees are masked, and in their personal vehicles, as they drive through the vaccination site. Each physician and healthcare worker provides their verification, identification, documentation and consent. They then extend their upper arm to receive the Pfizer vaccination. Following the receipt of the vaccination they have a 15-minute observation period to assure they do not experience any immediate side effects. These Tier 1A healthcare employees were encouraged to schedule their vaccination after their completed work schedule to have time to rest. As with all vaccinations, there is a potential for injection site reactions (redness, swelling and pain) as well as fever, fatigue, headache, chills, vomiting, diarrhea, muscle pain and/or joint pain. Fever is not an infrequent side effect, especially on the 2nd dose, so these vaccinated employees will self-monitor their temperatures, as they cannot work at Renown with a fever. Además de Luis, verá, primero en su camión el Dr. Bret Frey, que representa al personal médico y a los médicos de emergentología de Renown; el enfermero Matt Polak, supervisor de Enfermería Clínica de la Unidad de Cuidados Intensivos Respiratorios de Renown; Holly Irwin, terapeuta clínica de enfermedades respiratorias en su vehículo; Alexis Bertauche, especialista en enfermedades respiratorias en su vehículo; Eric Whitney, el supervisor que representa a los 168 miembros del equipo de Servicios Ambientales de Renown que han implementado grandes medidas de desinfección durante toda la pandemia; médicos representantes de socios de la Facultad de Medicina de la UNR, de la Reno Orthopedic Clinic, del Surgery Center of Reno y de toda la comunidad. Un futuro más prometedor para Luis Luis ha estado trabajando en el Renown’s Alternate Care Site, en la estructura de estacionamiento de Mill Street desde que se inauguró para atender pacientes a mediados de noviembre. Ha estado en Renown desde 2016, donde comenzó como flebotomista y lo alentaron a seguir una carrera profesional en el campo de la medicina. He applied to work as a technician on Renown’s Clinical Decision Unit- a short stay unit within the hospital for people who need clinical care, but do not need to be admitted to the hospital. Luis worked with patients and clinicians in the Clinical Decision Unit for a year before requesting to work in Renown’s innovative Alternate Care Site, built for patients recovering from COVID-19, for additional care before they returned home. Luis was scheduled to take the Medical College Admission Test® in April of this year to fulfill his dreams of becoming a doctor, but the COVID-19 pandemic forced him to change his plans. He plans to reschedule his medical school admission exam in February. He is excited to begin his training, possibly at UNR School of Medicine, and hopes one day to be a physician caring competently and compassionately for those in need. Luis has so much to look forward to, after such a difficult year. Luis cumplió 33 años en octubre y, en su cumpleaños, se contagió de COVID-19 después de asistir a una fiesta familiar. He experienced fever and noticed how dramatically the COVID-19 virus affected his breathing, his lungs, and his energy level. After spending time at home recovering, Luis recovered, tested negative, and returned to work. Como resultado de su experiencia y su interés en la medicina, Luis ha investigado mucho sobre la vacuna. Luis es bilingüe y es voluntario de CARE Chest de Sierra Nevada, una organización sin fines de lucro que proporciona equipos y suministros médicos, y asistencia con recetas de forma gratuita a poblaciones marginadas, cuando no trabaja en Renown. La vacuna: una herramienta más para ayudar a combatir la pandemia: “La mejor protección contra la COVID-19 será una combinación de vacunarse contra la COVID-19, usar mascarilla, mantenerse al menos a 6 pies de distancia de otras personas, evitar las multitudes y lavarse las manos con frecuencia”, dice Amy McCombs, máster en enfermería, enfermera certificada, CCRN, CNML, vicepresidenta de Calidad de Servicios Agudos de Renown y líder en el esfuerzo de vacunación de Renown. “No one tool alone will stop this pandemic, it will take a combination of all of us using all of these efforts to fight the spread of this virus. Though there has been positive news about vaccine development, no one knows when those vaccines will be ready for widespread use. In the meantime, everyone must remain vigilant, take precautions and follow public health orders.” “This vaccination is a game-changer in terms of improving the health of our community,” said Paul Sierzenski, MD, MSHQS, Chief Medical Officer, Acute Services, Renown Health. "Given the demands of this COVID-19 pandemic, we are pleased to be able to provide this vaccination to help in the fight. We will follow CDC recommendations for a tiered approach to vaccine distribution. Our goal is that by spring, all Renown physicians; employees and their family members; and all Hometown Health members and Renown patients interested in receiving the vaccine will have an opportunity to be vaccinated.” The COVID-19 vaccine is not mandatory for all Renown employees, but is strongly advised. Renown is covering all costs of the vaccine, and it is being offered free of charge to employees. Regístrese en Renown EPIC MyChart ahora. Para simplificar el proceso de notificación, consentimiento, programación y recordatorio para la distribución de vacunas, y para publicar en el sistema estatal de información de inmunización Web IZ de Nevada, las personas que estén interesadas en recibir la vacuna a través de Renown tendrán que registrarse y obtener una cuenta EPIC MyChart. Manténgase actualizado sobre la COVID-19 Renown Health está preparada para evaluar, diagnosticar y atender de manera segura a pacientes con enfermedad respiratoria, incluida la COVID-19. Para mantenerse actualizado sobre las comunicaciones relacionadas con la distribución de la vacuna contra la COVID-19 por parte de Renown, las preguntas frecuentes y la evidencia científica detrás de la vacuna, visite https://covid.renown.org/ Únase al equipo de Renown Renown Health continúa comprometido con la contratación de personas para ocupar puestos clave en la organización para apoyar la salud y el bienestar de nuestra comunidad. Para unirse a la familia de Renown y luchar por la causa justa, postule en línea en https://careers.renown.org/ Apoye al equipo de Renown Renown Health, una organización benéfica sin fines de lucro, está muy agradecida por el apoyo de la comunidad durante estos momentos sin precedentes. Para donar a pacientes o proveedores de Renown, visite https://www.renown.org/donations-covid-19/. About Renown Health Renown Health is a locally governed and locally owned, not-for-profit integrated healthcare network serving northern Nevada, Lake Tahoe and northeast California. Renown es uno de los mayores empleadores privados de la región y cuenta con una fuerza laboral de más de 7,000. It comprises three acute care hospitals, a rehabilitation hospital, the area’s most comprehensive medical group and urgent care network, and the region’s largest and only locally owned not-for-profit insurance company, Hometown Health. Renown has a long tradition and commitment to continually improve the care and the health of our community. Visite renown.org para obtener más información. About the Washoe County Health District The Washoe County Health District has jurisdiction over all public health matters in Reno, Sparks, and Washoe County through the policy-making Washoe County District Board of Health. The District consists of five divisions: Administrative Health Services, Air Quality Management, Community and Clinical Health Services, Environmental Health Services and Epidemiology & Public Health Preparedness. More info can be found here.
Leer más About First COVID-19 Vaccines Administered to Physicians Today
-
Renown Institute Expands Partnership to Offer ELF Testing
Juntos, realizarán pruebas a más de 30,000 participantes del estudio elegibles antes de 2023 para determinar el riesgo de cirrosis y enfermedades relacionadas con el hígado. Renown Institute for Health Innovation (IHI) announced today that the organization and Gilead Sciences, Inc. will be joining forces with Siemens Healthineers to offer the Enhanced Liver Fibrosis (ELF™) Test to people with risks for nonalcoholic steatohepatitis (NASH) enrolled in the Healthy Nevada Project (HNP). The ELF Test will help identify people most at risk for progressing to cirrhosis and liver-related outcomes and allow healthcare providers to intervene before irreparable damage occurs. This noninvasive blood test uses three serum biomarkers to create an ELF score from a predefined algorithm, which can be used by doctors to help evaluate if a patient requires increased medical care and monitoring for their condition. La enfermedad de hígado graso no alcohólico (EHGNA), que incluye la EHNA, es frecuente en Nevada y está subdiagnosticada, y probablemente afecte a más de 500,000 adultos en nuestro estado. If undetected and untreated, NASH can result in liver cirrhosis and may require liver transplantation or lead to death. Hay más de 12,000 personas en la lista de espera para trasplante de hígado en los EE. UU. y esta cifra continúa aumentando debido al incremento en la prevalencia de la EHGNA. “Thanks to important data collected through our Nonalcoholic Steatohepatitis Liver Disease Genome Atlas study, we now know that NASH is prevalent in the state of Nevada,” said Tony Slonim, M.D., DrPH, FACHE, president and CEO of Renown Health. “We are proud to expand our partnership with Gilead and begin working with Siemens Healthineers to improve health of those with liver disease and to take early detection one step further by offering Enhanced Liver Fibrosis, ELF testing for patients of Renown Health. This test provides our team of highly-skilled physicians an advanced, noninvasive method to actively assess dynamic liver fibrosis in study participants and intervene whenever necessary, contributing to a healthier Nevada.” “Gilead believes that noninvasive tests, including the ELF Test, will help improve the experience of people living with NASH. These tests may help to diagnose liver disease, monitor disease progression and evaluate responses to treatment without the requirement for liver biopsy,” said Rob Myers, MD, Vice President, Liver Fibrosis Clinical Research at Gilead Sciences. “The ELF Test has proven itself to be a valuable tool in NASH management and we hope this partnership will further support its use in routine care.” “We are very pleased that NASH patients in the Healthy Nevada Project now have access to the ELF Test which offers clinically useful prognostic information for their condition with the convenience of a simple blood test. Using our advanced laboratory expertise together with Renown IHI and Gilead, we can work towards better understanding of NASH and liver disease in a representative patient population,” said Sebastian Kronmueller, Head of Molecular Diagnostics at Siemens Healthineers. “We launched the Healthy Nevada Project to help people understand more about their health, to identify serious health risks, and to give people access to innovations like the ELF Test, so they can live their best lives,” said Renown’s chief scientific officer, Dr. Joseph Grzymski, who is also a research professor at the Desert Research Institute and principal investigator of the Healthy Nevada Project. Es increíblemente gratificante poder informar hallazgos clínicos para ayudar a nuestros 50,000 participantes voluntarios del estudio y asistir a los proveedores de atención médica a ayudar a sus pacientes”. La provisión de la prueba de ELF se basa en una colaboración estratégica anunciada previamente entre el Renown IHI y Gilead en julio de 2019. Esta sociedad en curso tiene como objetivo recopilar y analizar datos de salud genéticos y electrónicos anónimos de 60,000 participantes del estudio elegibles con el fin de mejorar la comprensión de la EHGNA y la EHNA y para potencialmente orientar el desarrollo de opciones de tratamiento para estas enfermedades. Acerca de la EHGNA y la EHNA La EHGNA es una acumulación de grasa en el hígado en personas que no tienen antecedentes de abuso de alcohol. Es normal que el hígado contenga algo de grasa, pero si más del 5 por ciento del contenido hepático es grasa, se considera hígado graso (esteatosis). NASH is the most severe form of NAFLD in which a person has liver cell damage and inflammation of the liver. Inflammation and liver cell damage can cause fibrosis, or scarring of the liver, and can cause decreased liver function (1). The symptoms of NASH are often silent or non-specific, making it difficult to diagnose. Aproximadamente, un tercio de las personas con EHNA desarrollan cirrosis o daño hepático irreversible (2). About the ELF™ Test The ELF Test is a noninvasive blood test that can quickly identify which patients are at an elevated risk for developing cirrhosis and other liver-related clinical events (LREs). In contrast to standard liver enzyme tests that reflect liver damage that has already occurred, the ELF Test combines three serum direct biomarkers of active fibrosis. The ELF Test algorithm measures each of these biomarkers to create an ELF score, which can be used as an aid to assess the risk for future disease progression. Doctors may use this ELF score to help evaluate if a patient requires increased medical care and monitoring for their condition. Individuals interested in determining their risk for NASH and its progression are encouraged to enroll in the Nonalcoholic Steatohepatitis Liver Disease Genome Atlas study. Those who have already consented and participated in the study will be contacted with more information on how to receive an ELF blood test. Para obtener más información o para inscribirse, comuníquese a la casilla de correo RenownIHI@renown.org o al teléfono (775) 982-6914. The Enhanced Liver Fibrosis (ELF™) Test kit is not available for sale in the U.S. Product availability may vary from country to country and is subject to varying regulatory requirements. In the U.S., the ELF Testing Service is available from Siemens Healthcare Laboratory, LLC (SHL), a CLIA-certified laboratory located in Berkeley, Calif. The ELF Testing Service, including the establishment of performance characteristics, was developed by SHL. The ELF Test has not been cleared or approved by the U.S. Food and Drug Administration. SHL is regulated under CLIA as qualified to perform high complexity testing. The ELF Test is used for clinical purposes and should not be regarded as investigational use only or research use only. About Renown Health Renown Health is the region’s largest, locally owned and governed, not-for-profit integrated healthcare network serving Nevada, Lake Tahoe and northeast California. Con una fuerza laboral diversa de más de 7,000 empleados, Renown ha fomentado una cultura de excelencia, determinación e innovación de larga data. La organización se compone de un centro de urgencias, dos hospitales de cuidados agudos, un hospital infantil, un hospital de rehabilitación, un grupo médico y una red de atención de urgencias y Hometown Health, la compañía de seguros sin fines de lucro más grande de la región y de propiedad local, Hometown Health. Renown’s institute model addresses social determinants of health and includes: Child Health, Behavioral Health & Addiction, Healthy Aging and Health Innovation. Clinical institutes include: Cancer, Heart and Vascular Health, Neurosciences and Robotic Surgery. Actualmente, Renown está inscribiendo participantes en el estudio genético de salud poblacional basado en la comunidad más grande del mundo, el Healthy Nevada Project®. For more information visit, renown.org. About the Renown Institute for Health Innovation Renown Institute for Health Innovation is a collaboration between Renown Health - a locally governed and locally owned, not-for-profit integrated healthcare network serving Nevada, Lake Tahoe and northeast California; and the Desert Research Institute - a recognized world leader in investigating the effects of natural and human-induced environmental change and advancing technologies aimed at assessing a changing planet. Renown IHI research teams are focused on integrating personal healthcare and environmental data with socioeconomic determinants to help Nevada address some of its most complex environmental health problems; while simultaneously expanding the state’s access to leading-edge clinical trials and fostering new connections with biotechnology and pharmaceutical companies. Learn more at healthynv.org. Renown Health es la red de atención médica más completa e integrada de Nevada y mantiene registros médicos electrónicos para 1.02 millones de pacientes registrados. En 2016, Renown Health y el Desert Research Institute crearon el Healthy Nevada Project (HNP), el primer estudio de salud poblacional basado en la comunidad del país. En 2017, el HNP comenzó una sociedad con Helix para aprovechar sus servicios de salud poblacional, la secuenciación Exome+™ y las herramientas de participación del consumidor. The HNP is now an ongoing collaboration between Renown IHI, the Desert Research Institute, a global leader in environmental data and applied research, and Helix, a personal genomics company. HNP combines genetic, environmental, social and clinical data to address individual and community health needs with the goal of improving health across the state and the nation. El HNP actualmente tiene más de 60,000 participantes. For more information, visit healthynv.org. About Siemens Healthineers Siemens Healthineers AG (listed in Frankfurt, Germany: SHL) is shaping the future of Healthcare. As a leading medical technology company headquartered in Erlangen, Germany, Siemens Healthineers enables healthcare providers worldwide through its regional companies to increase value by empowering them on their journey towards expanding precision medicine, transforming care delivery, improving the patient experience, and digitalizing healthcare. Siemens Healthineers is continuously developing its product and service portfolio, with AI-supported applications and digital offerings that play an increasingly important role in the next generation of medical technology. These new applications will enhance the company’s foundation in in-vitro diagnostic, image-guided therapy, and in-vivo diagnostics. Siemens Healthineers also provides a range of services and solutions to enhance healthcare providers ability to provide high-quality, efficient care to patients. En el año fiscal 2020, que finalizó el 30 de septiembre de 2020, Siemens Healthineers, que tiene aproximadamente 54,000 empleados en todo el mundo, generó ingresos por €14.5 mil millones y un EBIT ajustado de €2.2 mil millones. Encontrará más información disponible en www.siemens-healthineers.com.Media Contacto de Siemens Healthineers: Lance LongwellM: 610-448-6341E: lance.longwell@siemens-healthineers.com
Leer más About Renown Institute Expands Partnership to Offer ELF Testing